Gabapentin
- Product NDC
- 70518-1469
- 11-digit product format
- 705181469
- Labeler code
- 70518
- Product ID
- 70518-1469_5a1d54d1-a271-dc45-e063-6294a90ab35d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090858
- Marketing category
- ANDA
- Marketing start
- 2018-10-05
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-1469 | 70518-1469-2 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 70518-1469 | 70518-1469-3 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-1469-3 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-1469-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-1469-3 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-1469-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 70518-1469-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 70518-1469-1 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 70518-1469-3 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 70518-1469-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 70518-1469-1 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 70518-1469-3 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 70518-1469-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 70518-1469-1 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 70518-1469-3 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-1469-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-1469-1 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-1469-3 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-1469-2 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-1469-1 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-1469-3 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-1469-6 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-1469-2 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-1469-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-1469-3 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-1469-6 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-1469-2 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-1469-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-1469-3 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-1469-6 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-1469-2 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-1469-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-1469-3 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-1469-6 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 70518-1469-3 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 70518-1469-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 70518-1469-2 | 367a005e9d99… | 383a685ebd0f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090858-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | |
| A090858-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | |
| A090858-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090858-001 | AB |
| A090858-002 | AB |
| A090858-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2010-12-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2010-12-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090858-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2010-12-17 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090858-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090858-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A090858-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A090858-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090858-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090858-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090858-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090858-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090858-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090858-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090858-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090858-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090858-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090858-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090858-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A090858-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090858-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090858-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gabapentin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GABAPENTIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6CW7F3G59X | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310432 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 78445dbf-c7cd-419f-a7be-72821e496628 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-1469-0 | Gabapentin | 30 in 1 BLISTER PACK | CAPSULE | 30 | 19 | |
| 70518-1469-1 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | CAPSULE | 90 | 19 | |
| 70518-1469-2 | Gabapentin | 180 in 1 BOTTLE, PLASTIC | CAPSULE | 180 | 19 | |
| 70518-1469-3 | Gabapentin | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 19 | |
| 70518-1469-4 | Gabapentin | 100 in 1 BOX | CAPSULE | 100 | 19 | |
| 70518-1469-5 | Gabapentin | 1 in 1 POUCH | CAPSULE | 1 | 19 | |
| 70518-1469-6 | Gabapentin | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 19 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-1469 | GABAPENTIN CAPSULE [REMEDYREPACK INC.] | 16 | Current NDC, Legacy NDC, 7 package rows | 20250223_78445dbf-c7cd-419f-a7be-72821e496628.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 78445dbf-c7cd-419f-a7be-72821e496628 | 2026-08-28 | Warnings, Adverse reactions | 090858 ANDA090858 70518-1469 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | d06380d0-c894-427e-b13e-5a8f9eb86a34 | 2026-08-21 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7652adc6-1aad-4422-b85c-0c6b11c23b73 | 2026-08-21 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | f0e7a6c9-ae6c-4259-81ab-a37db54e3c80 | 2026-08-19 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eb2f6784-e7be-41b6-871b-2c3c961664ab | 2026-08-19 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8a781649-3271-47a6-995f-50f91141a48a | 2026-08-19 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 6670a64f-7f58-479f-b285-394abb753e2e | 2026-08-19 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | ddb3a54f-5224-4024-8804-b2a2f01d885e | 2026-08-06 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fce0c123-29d7-42bf-8c8d-8be1772e2d99 | 2026-08-06 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 41844c21-9e2a-4332-a8ff-9b71ae9032b0 | 2026-07-30 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 722de2a9-38b3-4518-b262-ba0d1346d0ba | 2026-07-24 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1006139-7dfc-4d87-a5a9-aeb380c32d24 | 2026-07-15 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 6a0a75ac-e121-477b-a9d1-d11f588afc9d | 2026-07-14 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | 14d61caa-17ce-4fa2-90fb-1470f3864be8 | 2026-06-26 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 03031adf-d36b-45ec-944e-dfce5a5de91a | 2026-05-28 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | 2026-05-18 | Warnings, Adverse reactions | 090858 ANDA090858 |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 999f3685-2eac-467e-bed2-1d0c36aaf0ed | 2026-05-04 | Warnings, Adverse reactions | 090858 ANDA090858 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310432 | gabapentin 400 MG Oral Capsule | PSN | 78445dbf-c7cd-419f-a7be-72821e496628 | 19 |
| 310432 | gabapentin 400 MG Oral Capsule | SCD | 78445dbf-c7cd-419f-a7be-72821e496628 | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-1469-0 | 70518146900 | 30 CAPSULE in 1 BLISTER PACK (70518-1469-0) | 30 capsule | 2018-10-05 | 0000-00-00 | No | No | Current |
| 70518-1469-1 | 70518146901 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70518-1469-1) | 90 capsule | 2019-07-09 | 0000-00-00 | No | No | Current |
| 70518-1469-2 | 70518146902 | 180 CAPSULE in 1 BOTTLE, PLASTIC (70518-1469-2) | 180 capsule | 2019-07-09 | 0000-00-00 | No | No | Current |
| 70518-1469-3 | 70518146903 | 30 in 1 BOTTLE, PLASTIC | Historical | |||||
| 70518-1469-4 | 70518146904 | 100 POUCH in 1 BOX (70518-1469-4) / 1 CAPSULE in 1 POUCH (70518-1469-5) | 100 pouch | 2018-10-05 | No | No | Current | |
| 70518-1469-5 | 70518146905 | 1 in 1 POUCH | Historical | |||||
| 70518-1469-6 | 70518146906 | 60 CAPSULE in 1 BOTTLE, PLASTIC (70518-1469-6) | 60 capsule | 2023-09-12 | No | No | Current | |
| 70518-1469-7 | 70518146907 | 100 POUCH in 1 BOX (70518-1469-7) / 1 CAPSULE in 1 POUCH (70518-1469-8) | 100 pouch | 2026-08-28 | No | No | Current |